The Medical Xchange

  • Edit profile
  • Logout
Login    Register

eLearning

eLearning Program

New Treatment Option for Anemia in Patients with CKD or on Dialysis

Dr. Andrew Steele — Length: 08:06

This eXtract video features key information from the American Society of Nephrology (ASN) Kidney Week 2019. This quick tour with an expert focuses on data presented from the OLYMPUS, ROCKIES and HIMALAYAS trials. In patients with chronic kidney disease (CKD) or on dialysis, a novel therapy is poised to reorder treatment options for anemia, according to the data presented from these global phase 3 studies.

eLearning Program

Reducing Bleeding Risk While Maintaining Ischemic Benefit: The TWILIGHT Study

Dr. Shamir R. Mehta — Length: 04:57

This eXtract video features key information from the American Heart Association (AHA) 2019 Scientific Sessions. This quick tour with an expert focuses on data presented on the primary TWILIGHT study and ACS subgroup analysis. The results show that following a high-risk PCI, withdrawal of aspirin while continuing ticagrelor monotherapy, resulted in a significant reduction of major bleeding risk without compromising ischemic benefit.

eLearning Program

Efficacy of Small Molecule JAK Inhibitor: SELECT-COMPARE 48 Week Results

Dr. Janet Pope — Length: 07:18

This eXtract video features key information from the 2019 American College of Rheumatology and the Association of Rheumatology Professionals Annual Meeting. This quick tour with an expert focuses on 48-week data presented from the SELECT-COMPARE trial. These data confirm the safety and efficacy of a small molecule JAK inhibitor to treat patients with moderate to severe rheumatoid arthritis.

eLearning Program

Dispelling Myths and Understanding the Importance of MMR-MMRV Childhood Vaccination

Dr. Donald C. Vinh — Length: 28:45

The measles/mumps/rubella (MMR) vaccine has been available in Canada since the 1970s and routine vaccination has reduced the incidence of these diseases by 99%. The MMR vaccine is also available in combination with varicella (MMRV). However, not all children are receiving these vaccines, despite the fact that these diseases can cause serious morbidity and even mortality. This program will review the diseases, the vaccines that prevent them, describe vaccine hesitancy and provide tips and tricks on how to educate parents on the importance of these vaccines.

eLearning Program

Inhaled Corticosteroids (ICS) and COPD: Myths vs Reality

Dr. Ronald Grossman — Length: 41:34

In the 1980s, inhaled corticosteroids (ICS) were adopted for use in chronic obstructive pulmonary disease (COPD) on the basis of their effectiveness in asthma, rather than on scientific evidence. In fact, evidence supporting their use in COPD is equivocal and their positioning in guidelines controversial. Despite this, evidence shows that ICS are being over-prescribed when they are not recommended. This program will review treatment objectives, the evidence and myths surrounding the use of ICS in COPD, better define which patients may benefit from ICS-containing therapy, and refocus on individualized treatment regimens.

eLearning Program

Improving Canadian Uptake and Acceptance of Herpes Zoster Vaccination: NACI Recommendations

Dr. Donald C. Vinh — Length: 11:30

This eXtract video features key information on shingles, the associated patient burden, available herpes zoster (HZ) vaccines as well as the NACI 2018 recommendations regarding the use of these vaccines. While there are available vaccines to prevent the occurrence of HZ, some still refuse immunization. Recommendations from health care providers are pivotal in the effort to build confidence in immunization against vaccine preventable diseases.

eLearning Program

Early Use of DMT is Pivotal to RRMS Patient Outcome

Anthony Traboulsee, MD — Length: 07:21

This eXtract video features key information from the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). This quick tour with an expert focuses on data presented from the 9-year CARE-MS II core study and CARE-MS and TOPAZ extension studies.

eLearning Program

Patients with HFpEF: Findings from the PARAGON-HF Trial

Anique Ducharme, MD, MSc, FRCP — Length: 07:39

This eXtract video features key information from the European Society of Cardiology (ESC) Congress. This quick tour with an expert focuses on data presented from the PARAGON-HF trial. The data may provide a challenge to the current definition of HFpEF.

This web site is solely for healthcare professionals

Yes, I am a healthcare professional No, I am not a healthcare professional
×
New user?
×
Sign up for the Medical Xchange Here you'll find expert commentary from the most recent medical meetings around the world, as well as features and interviews with top healthcare professionals.
First name* Last name*
Title Gender*
Email* Confirm Email*
Password* Password must have at least 8 characters with at least one Capital letter, one lower case letter and one number or special character Confirm Password*
Profession* Speciality*
Country* Province*